Sign up to save your podcastsEmail addressPasswordRegisterOrContinue with GoogleAlready have an account? Log in here.
It's a podcast discussing recent exciting scientific findings in biology and medicine. Powered by Firstory Hosting... more
FAQs about Let's talk science:How many episodes does Let's talk science have?The podcast currently has 8 episodes available.
February 28, 2026Whole-organ and whole-body 3D atlases enable cellome-wide profilingResearchers have developed the CUBIC Organ and Body Atlas, a high-resolution 3D framework designed for single-cell analysis across entire mammalian organisms. This resource utilizes advanced tissue clearing and a specialized light-sheet microscopy system called exMOVIE to achieve rapid, cellular-level imaging of intact organs and neonatal bodies. By converting these massive datasets into point cloud coordinates, the team enables precise quantification of cell numbers, densities, and spatial distributions in healthy and diseased states. The study demonstrates the atlas’s utility by mapping pathological changes in kidney injury and lung inflammation, as well as tracking systemic immune cell recruitment. This open-source platform serves as a "white map" for the scientific community, allowing for the integration of multimodal biological data into a standardized spatial context. Powered by Firstory Hosting...more21minPlay
February 20, 2026GLP-1 Receptor Agonists and the Cardiovascular SystemThis review from The Journal of Clinical Investigation examines the extensive impact of GLP-1 receptor agonists on the cardiovascular system. Preclinical research demonstrates that these therapies provide direct vascular protection by reducing inflammation and stabilizing atherosclerotic plaques, often independently of weight loss or glucose levels. In clinical settings, large-scale trials have confirmed that long-acting versions of these drugs significantly lower the risk of major adverse cardiovascular events, such as heart attacks and strokes. The text also highlights the emerging benefits for patients with heart failure, particularly those with the obesity-related preserved ejection fraction phenotype. Ultimately, the authors position these medications as a foundational treatment for reducing cardiovascular risk in individuals with type 2 diabetes, kidney disease, or obesity. This comprehensive overview bridges the gap between molecular mechanisms and real-world therapeutic outcomes in modern medicine. Powered by Firstory Hosting...more45minPlay
February 19, 2026ILF3 Mediates Transcriptional Adaptation via mRNA Decay IntermediatesThis Science paper explores transcriptional adaptation, a biological resilience mechanism where the breakdown of mutated messenger RNA triggers the increased expression of related healthy genes. Investigators identified the RNA-binding protein ILF3 as a critical bridge that connects cytoplasmic decay to the activation of genes within the nucleus. By utilizing specialized tiling oligonucleotide screens, the team discovered specific mRNA fragments that act as triggers for gene up-regulation through homology-mediated base pairing with antisense transcripts. These trigger sequences were found to be effective not only for compensating with similar genes but also for self-activating the primary gene, which could help address human genetic disorders caused by haploinsufficiency. The findings suggest that programmable oligonucleotides can be specifically designed to mimic this natural pathway to therapeutically enhance gene expression. Ultimately, this work provides a detailed molecular framework for how cells maintain genetic robustness despite deleterious mutations. Powered by Firstory Hosting...more17minPlay
February 13, 2026Gemini for Google Workspace Prompting Guide 101This guide details how to use Gemini for Google Workspace to increase productivity. Effective prompts should include Persona, Task, Context, and Format. The AI assists with writing, data organization, and image creation while maintaining privacy and security across all apps. Powered by Firstory Hosting...more15minPlay
February 07, 2026Oral PCSK9 Inhibition with Enlicitide for LDL Cholesterol ReductionThe CORALreef Lipids trial found that enlicitide, an oral PCSK9 inhibitor, significantly reduces LDL cholesterol by over 55% compared to placebo. Treatment also improved apolipoprotein B and lipoprotein(a) levels. The drug was well-tolerated with safety results similar to placebo. Powered by Firstory Hosting...more13minPlay
February 04, 2026HPCS: A Dynamic Hub for Lung Cancer Growth and ResistanceCancer plasticity drives tumor progression and treatment resistance. Research identifies a high-plasticity cell state (HPCS) in lung adenocarcinoma that enables diverse cellular transitions. Targeting the HPCS or its molecular programs may improve clinical cancer management. Powered by Firstory Hosting...more15minPlay
February 02, 2026Macrophage-derived thromboxane A2 drives neonatal cardiac regenerationLantz et al. reveal that neonatal heart regeneration relies on macrophages using the MERTK receptor to engulf dying cells, stimulating thromboxane A2 (TXA2) production. TXA2 activates the TP receptor on cardiomyocytes to induce proliferation via YAP signaling, an immune-metabolic pathway necessary for regeneration that is absent in adults. Powered by Firstory Hosting...more16minPlay
February 02, 2026Human longevity is 50% determined by your genomeLet's talk about a recent Science paper showing that our life span is decided 50% by our genome. Powered by Firstory Hosting...more15minPlay
FAQs about Let's talk science:How many episodes does Let's talk science have?The podcast currently has 8 episodes available.